Internal Medicine Alert – May 30, 2013
May 30, 2013
View Issues
-
Healthy Physicians Equal Healthy Patients
More patients who received a preventive medicine intervention also had their physician receive the corresponding preventive intervention. -
Hemorrhagic Stoke with Dual Antiplatelet Therapy
The authors concluded that in CAD patients, a history of CVE increased the risk of subsequent cardiovascular events, including hemorrhagic stroke. -
Large Systematic Review of Vitamin and Antioxidant Supplements Finds No Impact on Risk of CVD
A systematic review and meta-analysis of 50 randomized controlled trials did not find that vitamin and antioxidant supplements reduce the risk of cardiovascular disease. Numerous subgroup analyses similarly found no benefit from daily supplementation, but also no adverse effects. -
Brief Reports
Mediterranean Diet Can Reduce Risk for Stroke; Low Levels of Light Exposure Associated with Higher Stroke Incidence -
Pharmacology Update: Acyclovir Buccal Tablets (Sitavig)
The FDA has approved a buccal formulation of Acyclovir for the treatment of recurrent cold scores. The product uses a mucoadhesive technology that delivers the drug in high concentration to the site of the cold sore. Acyclovir buccal tablets are manufactured by Farmea in France and marketed as Sitavig by BioAlliance Pharma. -
Clarification
-
Clinical Briefs By Louis Kuritzky, MD
Are OSA Outcomes Better in the Hands of Sleep Specialists than Primary Care Clinicians?; Inhaled Steroids Increase Risk of TB in COPD Patients